Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
Hassan Mobayed,1,* Maryam Al-Nesf,1,* Tayseer Ibrahim,1 Sami Aqel,1 Mona Al-Ahmad,2,3 Jean Bousquet4– 6 1Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; 2Department of Microbiology, College of Medicine, Kuwait University, Kuwai...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-05-01
|
| Series: | Journal of Asthma and Allergy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/secondary-non-response-to-biologic-treatment-in-patients-with-severe-a-peer-reviewed-fulltext-article-JAA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849683174497452032 |
|---|---|
| author | Mobayed H Al-Nesf M Ibrahim T Aqel S Al-Ahmad M Bousquet J |
| author_facet | Mobayed H Al-Nesf M Ibrahim T Aqel S Al-Ahmad M Bousquet J |
| author_sort | Mobayed H |
| collection | DOAJ |
| description | Hassan Mobayed,1,* Maryam Al-Nesf,1,* Tayseer Ibrahim,1 Sami Aqel,1 Mona Al-Ahmad,2,3 Jean Bousquet4– 6 1Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; 2Department of Microbiology, College of Medicine, Kuwait University, Kuwait City, Kuwait; 3Al‐Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait; 4Macvia France, Montpellier, France; 5Hospital Charité, Institute of Allergology, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany; 6Department of Dermatology and Allergy, Comprehensive Allergy Center, Berlin Institute of Health, Berlin, Germany*These authors contributed equally to this workCorrespondence: Hassan Mobayed, Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, Tel +97455443313, Email hmobayedh@hamad.qa Maryam Al-Nesf, Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, Tel +97455820125, Email mariamali@hamad.qaAbstract: Biologic therapies have revolutionized the management of severe asthma (SA), offering significant symptom control and reduced exacerbations for many patients. However, up to 25% of individuals do not show satisfactory responses to these treatments and are categorized as non-responders. Definitions of response and primary non-response to biologics in SA are well-established. In secondary nonresponse, patients show initial response to biological treatment in the first 6– 12 months but later lose asthma control, and in SA this phenomenon remains undefined and unstudied in literature. We present 4 cases of severe asthma treated with different biologic agents. All patients demonstrated significant clinical improvement during the first 12 months of therapy but followed by a gradual loss of asthma control, indicative of secondary nonresponse. We discuss the clinical features, potential mechanisms, and implications of secondary nonresponse to biologics in severe asthma, highlighting an unmet need for further research to define this phenomenon and guide future therapeutic strategies.Keywords: severe asthma, biological treatment of severe asthma, non-response to biologics in severe asthma, secondary nonresponse to biologics in severe asthma, type 2 severe asthma |
| format | Article |
| id | doaj-art-744ed9de6b9345b5b2b69fa394c806a2 |
| institution | DOAJ |
| issn | 1178-6965 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Asthma and Allergy |
| spelling | doaj-art-744ed9de6b9345b5b2b69fa394c806a22025-08-20T03:23:59ZengDove Medical PressJournal of Asthma and Allergy1178-69652025-05-01Volume 18Issue 1795800103080Secondary Non-Response to Biologic Treatment in Patients with Severe AsthmaMobayed H0Al-Nesf M1Ibrahim T2Aqel S3Al-Ahmad M4Bousquet J5Department of Medicine, Allergy and Immunology DivisionDepartment of Medicine, Allergy and Immunology DivisionDepartment of Medicine, Allergy and Immunology DivisionDepartment of Medicine, Allergy and Immunology DivisionDepartment of MicrobiologyImmunology and AllergologyHassan Mobayed,1,* Maryam Al-Nesf,1,* Tayseer Ibrahim,1 Sami Aqel,1 Mona Al-Ahmad,2,3 Jean Bousquet4– 6 1Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; 2Department of Microbiology, College of Medicine, Kuwait University, Kuwait City, Kuwait; 3Al‐Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait; 4Macvia France, Montpellier, France; 5Hospital Charité, Institute of Allergology, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany; 6Department of Dermatology and Allergy, Comprehensive Allergy Center, Berlin Institute of Health, Berlin, Germany*These authors contributed equally to this workCorrespondence: Hassan Mobayed, Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, Tel +97455443313, Email hmobayedh@hamad.qa Maryam Al-Nesf, Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, Tel +97455820125, Email mariamali@hamad.qaAbstract: Biologic therapies have revolutionized the management of severe asthma (SA), offering significant symptom control and reduced exacerbations for many patients. However, up to 25% of individuals do not show satisfactory responses to these treatments and are categorized as non-responders. Definitions of response and primary non-response to biologics in SA are well-established. In secondary nonresponse, patients show initial response to biological treatment in the first 6– 12 months but later lose asthma control, and in SA this phenomenon remains undefined and unstudied in literature. We present 4 cases of severe asthma treated with different biologic agents. All patients demonstrated significant clinical improvement during the first 12 months of therapy but followed by a gradual loss of asthma control, indicative of secondary nonresponse. We discuss the clinical features, potential mechanisms, and implications of secondary nonresponse to biologics in severe asthma, highlighting an unmet need for further research to define this phenomenon and guide future therapeutic strategies.Keywords: severe asthma, biological treatment of severe asthma, non-response to biologics in severe asthma, secondary nonresponse to biologics in severe asthma, type 2 severe asthmahttps://www.dovepress.com/secondary-non-response-to-biologic-treatment-in-patients-with-severe-a-peer-reviewed-fulltext-article-JAASevere asthmabiological treatment of severe asthmanon-response to biologics in severe asthmasecondary nonresponse to biologics in severe asthmaType 2 severe asthma. |
| spellingShingle | Mobayed H Al-Nesf M Ibrahim T Aqel S Al-Ahmad M Bousquet J Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma Journal of Asthma and Allergy Severe asthma biological treatment of severe asthma non-response to biologics in severe asthma secondary nonresponse to biologics in severe asthma Type 2 severe asthma. |
| title | Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma |
| title_full | Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma |
| title_fullStr | Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma |
| title_full_unstemmed | Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma |
| title_short | Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma |
| title_sort | secondary non response to biologic treatment in patients with severe asthma |
| topic | Severe asthma biological treatment of severe asthma non-response to biologics in severe asthma secondary nonresponse to biologics in severe asthma Type 2 severe asthma. |
| url | https://www.dovepress.com/secondary-non-response-to-biologic-treatment-in-patients-with-severe-a-peer-reviewed-fulltext-article-JAA |
| work_keys_str_mv | AT mobayedh secondarynonresponsetobiologictreatmentinpatientswithsevereasthma AT alnesfm secondarynonresponsetobiologictreatmentinpatientswithsevereasthma AT ibrahimt secondarynonresponsetobiologictreatmentinpatientswithsevereasthma AT aqels secondarynonresponsetobiologictreatmentinpatientswithsevereasthma AT alahmadm secondarynonresponsetobiologictreatmentinpatientswithsevereasthma AT bousquetj secondarynonresponsetobiologictreatmentinpatientswithsevereasthma |